All posts by imreal

Hge Health Enrolls Transplant And Surgical Patients In Its Covid Care(Tm) Monitoring Platform To Protect Vulnerable Patients From The Growing Covid-19 Pandemic


“HGE Health can help keep highly vulnerable and clinically fragile lung, heart, kidney, and liver transplant patients stable and act as a bridge between patients and their physicians during a time when COVID-19 pandemic has severely limited the availability of existing resources,” said Dr. Markus

To avoid compromising the immune system of transplant recipients or patients waiting for a transplant during the COVID-19 pandemic, Temple Health has begun enrolling lung, heart, kidney, and liver transplant patients using HGE Health’s COVID Care(TM) platform. Over 350 transplant patients were enrolled within days of the pandemic to monitor pre- and post-transplant patients for COVID019 symptoms and immediately care for those patients who exhibit symptoms.

Underlying health conditions warranting a transplant can compromise the immune system, making pre-transplant patients susceptible to severe COVID infection. Similarly, transplant recipients are commonly prescribed immunosuppressants that lower the body’s ability to reject a transplanted organ. However, suppressing the body’s ability to reject a transplanted organ also inhibits the body’s immune system from warding off infections such as a COVID-19 infection. Thus, both pre- and post-transplant patients are at high risk for severe COVID-19 infection and morbidity.

Patients enrolled in HGE Health’s COVID Care(TM) remote symptom monitoring platform report their symptoms daily, from home. Questions prepared in accordance with guidelines issued by the Centers for Disease Control (“CDC”) seek information about any symptoms or other conditions experienced by enrolled patients that suggest possible exposure to, or contraction of the COVID-19 virus. “Our platform presents the reported symptom data for our enrolled patients in a format that allows those with the highest risk of infection to be prioritized for medical care” explained Michael J. Markus, Ph.D., CEO of HGE Health. “Transplant patients who are awaiting a transplant or have received a transplant are among the group of patients who are the most susceptible to severe COVID-19 infections and require immediate attention if they contract the virus. The symptom data we collect allows for rapid treatment, often the same day the symptom data is received, so their caregivers can intervene and provide treatment to mitigate the effect of the virus on those patients. Thanks to their daily symptom reports, patients have the peace of mind knowing that they stand a better chance of remaining healthy while awaiting a transplant and that they have someone watching over them in their convalescence, regardless of where they are, following a transplant.”

Temple University Hospital (TUH), its Department of Thoracic Medicine and Surgery, and the Temple Lung Center — the most active lung disease and lung transplantation complex in the United States – are leveraging the scalable nature of the COVID Care(TM) platform to monitor their vulnerable transplant population. The resources of TUH are already strained due to inpatient visits seeking care for COVID-19 infections, in addition to TUH’s patient demands that existed before the current pandemic. Despite the surge in demand, TUH maintains the ability to monitor the symptoms of its transplant patients in real-time and prioritize those requiring medical intervention as part of its comprehensive care program. Any transplant patients suspected of having contracted COVID-19 can be treated quickly, often at the patients’ homes.

Transplant patients, pre- and post-procedure, who are enrolled in the COVID Care(TM) platform use their smartphone, computer or other terminal to securely submit any symptoms of COVID-19 on a daily basis. The reported symptoms are used to categorize the transplant patients into risk categories, taking their potentially compromised immune system into consideration, enabling TUH to rapidly respond to those with the highest risk of a severe COVID-19 infection.

“We recognize that transplant patients, especially during this COVID-19 pandemic, are highly vulnerable and clinically fragile,” said Dr. Markus. “However, if we can help keep lung, heart, kidney, liver and other organ transplant patients stable during a time when the pandemic has severely limited the availability of existing resources, HGE Health can be the critical bridge between patients and their physicians.”

COVID-19 has now spread around the world, infecting more than 400,000 and killing more than 17,000. The World Health Organization (“WHO”) recognizes that the severity of Coronavirus is linked to the age and health condition of patients and has recently declared it a pandemic. Patients of advanced age (at least 60 years old) and diagnosed with a co-morbid disease are the most likely to experience a severe infection of Coronavirus. HGE Health’s digital platform and technology-enabled services, called HGE Care, allows physicians to remotely care for patients from anywhere in the nation, and help patients better understand and manage changes in their symptoms.

Editor’s Note: HGE Health Care Solutions is the exclusive licensee to certain Temple University intellectual property.

Dr. Gerard Criner, Director of the Temple Lung Center, is the founder and Chairman of the Board of Directors of HGE Health.

Temple University and Dr. Criner hold minority equity positions in the company.

About HGE Health

Headquartered in Fort Washington, PA, HGE Health harnesses its deep experience in chronic disease management and digital health in pulmonary disease, telemedicine, and mobile health to develop a clinical services platform that delivers better care faster at a much lower cost for patients, physicians and payors. Built on clinical protocols developed and supported by 16 years of research, the company’s technology has compiled the longest-running and world’s largest longitudinal data set of COPD symptoms, interventions, and clinical management to help physicians provide care for a geographically and socio-economically diverse COPD and pulmonary patient population.

About Temple Health

Temple University Health System (TUHS) is a $2.2 billion academic health system dedicated to providing access to quality patient care and supporting excellence in medical education and research. The Health System consists of Temple University Hospital (TUH); TUH-Episcopal Campus; TUH-Jeanes Campus; TUH-Northeastern Campus; The Hospital of Fox Chase Cancer Center and Affiliates, an NCI-designated comprehensive cancer center; Temple Transport Team, a ground and air-ambulance company; Temple Physicians, Inc., a network of community-based specialty and primary-care physician practices; and Temple Faculty Practice Plan, Inc., TUHS’s physician practice plan comprised of more than 500 full-time and part-time academic physicians in 20 clinical departments. TUHS is affiliated with the Lewis Katz School of Medicine at Temple University.

Temple Health refers to the health, education and research activities carried out by the affiliates of Temple University Health System (TUHS) and by the Katz School of Medicine. TUHS neither provides nor controls the provision of health care. All health care is provided by its member organizations or independent health care providers affiliated with TUHS member organizations. Each TUHS member organization is owned and operated pursuant to its governing documents.

It is the policy of Temple University Health System that there shall be no exclusion from or participation in, and no one denied the benefits of, the delivery of quality medical care on the basis of race, ethnicity, religion, sexual orientation, gender, gender identity/expression, disability, age, ancestry, color, national origin, physical ability, level of education, or source of payment.

Claims process underway for parents and guardians of babies born opioid-dependent to obtain relief


Representatives fighting for children born exposed to opioids while fetuses in their mother’s womb are encouraging their parents, grandparents, and guardians, to file a proof of claim in order to qualify to obtain compensation from Purdue—reportedly up to $6 billion in funds will be made available by Purdue as part of its bankruptcy settlement.

“The COVID-19 national emergency has dominated the news media and other public communications outlets that otherwise could have notified these same parents and guardians of the need to take immediate action in the best interests of their children,” says Brylski, principal of New Orleans-based Brylski Company. Brylski is a spokesperson for Opioid Justice, a resource for attorneys fighting to end our nation’s opioid epidemic by identifying real solutions to the crisis. “We are waving a red flag that families need to contact an attorney today.”

The federal judge overseeing the Purdue bankruptcy proceedings is determined to swiftly reach an agreement over the distribution of the Purdue funds.

“To direct needed relief and assistance to children suffering from the complications of NAS it is vital that parents and guardians act now by filing a proof of claim,” said Donald Creadore, an attorney and member of the Ad Hoc Committee for NAS Children in the Purdue Bankruptcy action. “Right now, no determination has been made about how much of the reported $6 billion settlement will be directed towards relief and assistance to children suffering from the complications of NAS, so these families can make an impact and obtain relief by acting today to have their needs fully represented.”

Brylski says that exposure to opioids in the womb has resulted in birth defects, such as club foot, spina bifida, heart defects, cleft palate, hydrocephalus, esophageal atresia, gastroschisis, anorectal atresia, anddiaphragmatic hernia. The most common adverse outcomes upon birth include body shakes, excessive crying or yawning , feeding problems, diarrhea, sleeping problems, fever, or runny noses. As these children grow, many experience behavioral problems, cognitive delays, delayed speech and walking, mental or motor deficits, or attention-deficit disorder (ADD).

“With America more than two decades into a crisis triggered by over-prescription and abuse of prescription painkillers, the public is stunningly unaware of the dangers caused by pregnant women exposing – often unknowingly – babies in the womb to these opioids,” said Brylski.

There are already class actions filed in 43 states on behalf of such infants and children, said Ms. Brylski, but there is still time for more families to join these legal efforts.

“But the clock is ticking,” said Brylski.

Jennifer Scully is a 42-year-old career nurse who lives in upstate New York. Scully says she’s gotten used to the phone calls from the school attended by her 5-year-old daughter from teachers and staff who don’t understand the seizures occasionally experienced by her child, in which she would stare blankly into space for a minute or two, unresponsive to adults.

To Scully, the seizures are one more problem – on top of her child’s small size, limited vocabulary, and delayed potty training – that she connects with opioid exposure.

The career health-care professional trusted her doctors in 2014 when she unexpectedly became pregnant while under treatment for both the aftermath of a broken back and breast cancer, which is why she was on a drug regimen that included OxyContin.

“They said, ‘We’re not taking you off and besides, it won’t affect the baby,” Scully recalls. Instead, her newborn daughter spent five days in the hospital coping with the symptoms of NAS, including tremors and high-pitched crying. When they finally left the hospital, doctors insisted the worst that Scully would have to deal with would be an occasionally cranky baby – a gross underestimation of the developmental problems her daughter has faced.

“The number of American children – and families – affected had been grossly undercounted. Based on information that about one-in-three pregnant women in America — or roughly 1.3 million out of the 3.8 million women who gave birth — were given a prescription for opioid painkillers, our team has estimated that a baby with serious problems related to opioid exposure is born somewhere in the United States every 15 minutes,” said Ms. Brylski.

Nurse Scully is suing, like other impacted families, for long-term health care and a medical monitoring fund for children exposed to opioids in the womb. She says the big pharmaceutical firms “need to be held responsible for what they’ve done. I expected a healthy child. None of this is my fault.”

Children born exposed or dependent on prescription opioids due to the mother’s use of Oxycotin, Butran, Dilaudid, or other forms of oxycodone, tramadol or related prescription medicines can file a claim by calling (800) 529-8170 or going to http://www.opioidjusticeteam.com.

Share article on social media or email:

CISCRP Announces 2nd Annual Virtual Fitness Challenge to Recognize Medical Heroes


CISCRP will be initiating the 2nd annual Medical Hero Appreci-a-thon virtual fitness challenge to bring the global clinical research community together to express their appreciation for all “Medical Heroes” – medical and healthcare professionals, researchers and study volunteers.

On April 15, the Center for Information & Study on Clinical Research Participation (CISCRP) will be initiating the 2nd annual Medical Hero Appreci-a-thon to bring the global clinical research community together to express their appreciation for all “Medical Heroes” – medical and healthcare professionals, researchers and study volunteers. CISCRP invites the public to participate in this free month-long virtual fitness opportunity.

Participants can share the distance they will go to recognize Medical Heroes by tracking any form of exercise—cycling, running, elliptical, weightlifting, sit-ups, yoga, stair climbing, pet-walking and other physical activities—on the Appreci-a-thon portal. Donations received in support of the virtual fitness challenge provide educational programs designed to help patients and their families navigate the clinical research process.

“Last year, nearly 400 people across industry, research, advocacy, and patient communities participated globally in this virtual appreciation event and the spirit of support and teamwork was inspiring,” said event organizer Justine Holleran. “This year we’re hoping to see an even larger community participating in this virtual fitness challenge to raise awareness about clinical research and its importance to public health.”

“Clinical research education and awareness is even more critical today,” added Ellyn Getz, Associate Director, Development and Community Engagement, at CISCRP. “Medical, healthcare and research professionals are working tirelessly to provide care and treatment. And patients, their families and the public are seeking information and hope. Join us in showing your support and appreciation for the many dedicated ‘Medical Heroes’ around the world by participating in this virtual fitness challenge!”

The Medical Hero Appreci-a-thon virtual fitness challenge officially starts April 15th and runs through May 15th. Participants can register for free at https://www.ciscrp.org/events/appreci-a-thon.

For additional information, email medicalheroevents@ciscrp.org or visit https://www.ciscrp.org/events/appreci-a-thon

ABOUT CISCRP:

The Center for Information and Study on Clinical Research Participation is an award-winning nonprofit organization dedicated to educating and engaging the public, patients, research and health care professionals as partners in the clinical research process. Since 2003, CISCRP has produced numerous educational and awareness-building programs internationally and has developed a large library of print/digital content to increase health literacy.

Share article on social media or email:

How to Handle MDSAP Findings Management Report


WCG FDAnews

WCG FDAnews

Planning an Audit Response:

How to Handle MDSAP Findings

An FDAnews Management Report

https://www.fdanews.com/products/59568

Despite best efforts to the contrary, having nonconformities spotted by a notified body during an audit does happen. What is the best way to respond?

Companies will be under a strict deadline and under pressure with only 15 days to craft a response to the auditing body.

Planning an Audit Response: How to Handle MDSAP Findings will show readers how to develop a standard operating procedure (SOP) that tells everyone involved what needs to be done and when to do it. This management report provides step-by-step instructions for an audit response:

  • Evaluate the severity of the findings
  • Investigate the root cause
  • Identify corrections and corrective actions
  • Draft a written response to the auditing body
  • Prepare for follow-up audits
  • Establish a timeline that gets it all done by the auditor’s deadline

If one might be tasked with responding to a regulatory audit — or signing your name to one — this management report is a must.

Management Report Details:

Planning an Audit Response:

How to Handle MDSAP Findings

An FDAnews Management Report

https://www.fdanews.com/products/59568

Management Report PDF:

$397

Easy Ways to Order:

Online: https://www.fdanews.com/products/59568

By phone: 888.838.5578 or 703.538.7600

About FDAnews:

FDAnews is the premier provider of domestic and international regulatory, legislative, and business news and information for executives in industries regulated by the US FDA and the European Medicines Agency. Pharmaceutical and medical device professionals rely on FDAnews’ print and electronic newsletters, books and conferences to stay in compliance with international standards and the FDA’s complex and ever-changing regulations.

Share article on social media or email:

Viotek Reveals Upgrade With New GNV27DB 27” 2K Curved 144Hz Gaming Monitor


New GNV27DB 27” 2K Curved 144Hz Gaming Monitor

“Viotek strives to bring extreme value to the market. Our goal is to make high-performance gaming products accessible to a wider audience. We always use Grade A panels and components. For this reason we can offer a full three year zero dead pixel guarantee. V 4Victory.” – Brett Barbour, VP

The GNV27DB by Viotek® is a gaming powerhouse but is also flexible so movie lovers will bask in the full 96% of the sRGB gamut, 3000:1 contrast ratio for deep, inky blacks, and the 16:9 cinema format perfect for movies. The GNV27DB also features a tilt-adjustable stand and 75mm VESA mount conveniently hidden behind the stand to maximize flexibility.

The GNV27DB features the full Viotek gaming suite including user-accessible overdrive, GAMEPLUS targeting cursors, Freesync via adaptive sync, a 48-144Hz Freesync range with low framerate compensation below 48, works with G-Sync, FPS/RTS optimized gaming modes, a low blue light mode for long gaming sessions free from eye-sore, and PIP/PBP with true simultaneous dual inputs to watch your favorite twitch stream while playing.

Follow the action on Instagram, Facebook, and Twitter!

The three HDMI ports (2x 1.4 1x 2.0), DP 1.2 port, and 3.5mm audio port ensure the GNV27DB fits every situation, no matter how many consoles or PCs that you own. The GNV27DB is a true gaming center and is great for Xbox/PS4/Switch consoles without any additional effort. The anti-glare coat combined with the deep 1500R curve ensures glare is never an issue whether gaming or watching YouTube in 1440P.

Like all Viotek monitors, the GNV27DB is backed by a 3-year limited warranty and Viotek’s best-in-market Dead Pixel Policy. The GNV27DB is on sale for $259.99 (MSRP $285.99) respectively and is available now through Viotek.com, Amazon.com, and select retailers.

ABOUT VIOTEK®

Viotek is a different kind of tech company. Built on an unwavering will to innovate, Viotek is dedicated to making the best products at the best price for technology enthusiasts worldwide. With an imaginative research and development team and the resources to bring ideas to life, Viotek is committed to never follow but always lead. Viotek: V 4Victory.

Share article on social media or email:



Dr. Bart Rademaker Offers Free Classes On Stem Cell Therapy And The Coronavirus


Regenerative Medicine COVID-19

Dr. Bart Rademaker Stem Cell Therapy Info, Coronavirus

Stem cell therapy and regenerative medicine should be considered in the battle against the coronavirus. Dr. Rademaker offers in-depth information on these options.

Dr. Bart Rademaker, the long-time plastic surgeon who has branched out into stem cell therapy, is offering online classes to patients and doctors who are interested in learning more about regenerative medicine and the potential benefits on health in particular during this time with the coronavirus or COVID-19. Rademaker, has offered the therapy in his office for years and has been contacted by physicians and patients who wish to find out more information on the benefits it could have for those combating the virus as clinical trials are proceeding in many parts of the world.. The classes will be available beginning in April 2020 and include podcasts, blogs and other forms of information that are available online.

“The coronavirus has turned the world upside down and people are trying to gather any information they can. I’ve heard medical experts tell people to drink warm tea or water every 20 minutes. I’ve heard patients say they read that you can kill the virus with stem cell therapy. There is too much information going out there right now and I want to help patients and medical professionals get the facts on it. Based on my experience and my communication with experts in the field of regenerative medicine, I feel that I can offer some assistance.” Dr. Bart Rademaker

One of the main things the doctor wishes to stress to people who are unsure how to minimize exposure is that they need to follow the guidelines put in place by their government and information provided on personal hygiene and safety. This includes washing hands thoroughly with water and soap rather than rely on hand soap. Trying to avoid contact with your eyes and mouth unless you’ve recently washed your hands. Taking vitamins to strengthen your immune system. Staying away from people and avoiding areas like grocery stores as long as possible are other good recommendations provided that people should follow.

“People are not sure what to do because the information comes at them so quickly. Even doctors are not sure when their patient asks them if stem cell therapy is a safe option to prevent or treat the coronavirus. When I have doctors calling me just because they saw that I offer regenerative medicine information online, I knew it was time to start getting aggressive with these classes and offer my assistance to everyone.”

For more information you can call our team at: 727-748-7389

About Dr. Bart Rademaker

Dr. Bart Rademaker is based in Tampa, Florida and has over 20 years of experience as a well-respected medical professional. He has affiliations with several hospitals including Morton Plant and Mease Countryside. His degree is from Erasmus University Rotterdam Faculty of Medicine and added regenerative medicine to his practice four years ago.

Share article on social media or email:

GoParrot Founder Addresses Food Safety Standards During COVID-19


“These guidelines are the elements that have been missing throughout the COVID-19 conversation,” said Nissim. “And where there’s uncertainty, there is concern.”

Since the onset of the COVID-19 pandemic, there hasn’t yet been a clear guide for restaurants regarding food safety standards and practices. GoParrot ( https://www.goparrot.ai/) founder Yaniv Nissim has stepped up to the plate to address this gap. Nissim, along with doctors who specialize in virus control and food safety, has created new standards for delivering food during this time of COVID-19 so that consumers can feel reassured when they order in.

Guidelines collaborators include Nissim, whose company provides technology that supports touchless food delivery, as well as a PhD and College Professor, who has published over 50 papers in the area of food safety, and the Chief of Infectious Disease at a Major Academic Medical Center.

“These guidelines are the elements that have been missing throughout the COVID-19 conversation,” said Nissim. “And where there’s uncertainty, there is concern.”

According to Nissim and his panel, food and food containers have not been identified as ways to get or transfer the virus. It’s the person-to-person contact that is the culprit.

Furthermore, as Nissim explains, “as a matter of course, restaurants already follow regulations put in place by the FDA, CDC, and USDA designed to keep people healthy. These include proper handwashing and frequent cleaning of food preparation surfaces. But at times like these there is the opportunity to go above and beyond.”

Extra precautions that Nissim and his experts are recommending include:

By the restaurant:

  • Requiring anyone with COVID-19 symptoms to stay at home, out of the kitchen, and out of delivery vehicles
  • Going beyond cleaning and sanitizing food preparation surfaces to cleaning and disinfecting them with agents proven to kill the COVID-19 virus on contact
  • Asking delivery people to leave orders on the porch or outside the front door and then texting to let customers know they are there—this touchless transfer means that all menu charges and tips must be pre-paid online in advance by credit card
  • Having delivery personnel carry and use hand sanitizer between each and every drop off

By the customer:

  • Transferring food received from its packaging to a plate
  • Throwing away the packaging, the bag, and everything inside the bag
  • And most importantly, washing hands with soap and water after unpacking the delivery—and right before eating


Nissim is making the guidelines available to restaurants in the form of a certification badge for their websites to not only demonstrate the restaurant’s commitment to these new COVID-19 Food Safety Standards, but also give customers a few easy steps to take on their end as well.

About GoParrot

GoParrot provides high-end ordering technology to restaurant chains that do not have the capabilities or funds to develop it on their own and don’t want to pay the exorbitant fees to the popular delivery apps and companies. In addition, GoParrot allows restaurants to keep their analytics and customer relations, bringing the restaurants and their customers closer together through exceptional customer service. The company currently works directly with hundreds of restaurant brands, with access to over 400,000 restaurants through Square and Toast and delivery integrations with national and local partners including Postmates, Doordash, and Relay.

For additional information, visit: http://www.goparrot.ai/Covid-19

Share article on social media or email:

The Latest Guidance on Clinical Decision Support Software Webinar, April 7, 2020


WCG FDANews

WCG FDANews

FDA CDS Software Regulation:

The Latest Guidance on Clinical Decision Support Software

An FDAnews Webinar

Tuesday April 7, 2020, 1:30-3:00 p.m. EDT

https://www.fdanews.com/cdssoftwareregulation

*NEW: The webinar will be updated to include FDA regulation of AI used to guide clinical management of the Coronavirus.*

Is one’s software regulated as a medical device?

Does it provide computerized alerts and reminders for providers and patients, documentation templates, diagnostic support or contextually relevant reference information? Then, the software might be regulated as a medical device.

Join FDAnews and legal expert Bradley Merrill Thompson for a comprehensive overview of the latest legal, regulatory and compliance nuances of FDA’s guidance on clinical decision support (CDS) software:

•Master the legal, regulatory, and compliance nuances of the FDA’s guidance

•Determine what types of CDS software functions do not meet the definition of a device as amended by the Cures Act

•Assess which types of software meet the definition of a device for which the FDA may not enforce compliance under device requirements

•Comprehend how the FDA intends to leverage the Software as a Medical Device: Possible Framework for Risk Categorization and Corresponding Considerations External Link Disclaimer (IMDRF Framework) in its risk-based approach to CDS regulation

Establish compliant best practices for CDS software by understanding the legal, regulatory and compliance nuances of the FDA’s guidance.

Webinar Details:

FDA CDS Software Regulation:

The Latest Guidance on Clinical Decision Support Software

An FDAnews Webinar

Tuesday April 7, 2020, 1:30-3:00 p.m. EDT

https://www.fdanews.com/cdssoftwareregulation

Tuition:

$287 per site

Easy Ways to Register:

Online: https://www.fdanews.com/cdssoftwareregulation

By phone: 888.838.5578 or 703.538.7600

About FDAnews:

FDAnews is the premier provider of domestic and international regulatory, legislative, and business news and information for executives in industries regulated by the US FDA and the European Medicines Agency. Pharmaceutical and medical device professionals rely on FDAnews’ print and electronic newsletters, books and conferences to stay in compliance with international standards and the FDA’s complex and ever-changing regulations

Share article on social media or email:

University of Washington PA Freshman Wins SignatureCare Emergency Center’s 2020 Spring Semester Scholarship


SignatureCare Emergency Center, Odessa, TX

SignatureCare Emergency Center, Odessa, TX

I am very proud to have won this scholarship which I will be using to pay for my tuition. The scholarship will allow me to reach my dream of becoming a Physician Assistant.

Caitlin Richardson, a University of Washington MEDEX Physician Assistant (PA) program freshman has won SignatureCare Emergency Center’s 2020 Spring Semester Scholarship.

The $1,000 scholarship, awarded biannually to U.S. students who show passion and commitment to the medical and healthcare field, is aimed at helping the students pay tuition and other college-related expenses.

Rhonda Abbe, Director of Operations for SignatureCare Emergency Center, praised Richardson’s commitment to underserved communities.

“It’s inspiring to see her commitment and dedication to meeting the healthcare needs of those in the rural communities. She could easily have chosen to go into other branches of medicine but she saw a need and decided to fill it. That is admirable,” Abbe said.

Richardson said she decided to become a Physician Assistant after working alongside dedicated and passionate healthcare providers in rural Alaska.

She singled out Dr. Kathleen Todd of Valdez, Alaska, and Dr. Helene Eliassen of Anchorage, Alaska as her role models, and the forces behind her decision to become a PA.

“They incorporate characteristics that are important to me. I had the privilege of shadowing Dr. Helene Eliassen over the course of two summers. Helene is very personable as she makes every effort to understand each patient’s unique history. I value her open-mindedness and the way she treats everyone with the same level of respect,” Richardson said.

“Working alongside such dedicated and passionate medical providers in remote Alaska opened my eyes. My remote medical experience motivated me to grow beyond the medical laboratory into the role of a healthcare provider. For me, the decision to become a physician assistant combines the best of both worlds.

“Rural providers work in primary care where they get to follow their patients through all aspects of their medical journey, but they also staff the emergency room where they can be at the bedside when patients are at their worst,” she added.

Richardson said she was proud to have won the 2020 spring semester scholarship.

“I am very proud to have won this scholarship which I will be using to pay for my tuition. The scholarship will allow me to reach my dream of becoming a Physician Assistant.”

“After PA school, I would like to focus on wilderness medicine as well as leading search and rescue missions. I aspire to work as a PA in a critical access hospital, providing a mix of primary care, inpatient care, and emergency medicine services to remote locations,” she added.

About SignatureCare Emergency Center

SignatureCare Emergency Center owns and manages the fastest growing group of 24-hour emergency rooms throughout Texas. We currently have ERs in Houston (Houston Heights, Montrose, Copperfield, Memorial City, Westchase and Cypress/FM 1960), Bellaire, Sugar Land, Stafford, Killeen, Lewisville, Austin, College Station, Midland, Paris, Odessa and Texarkana.

Go to our website, https://ercare24.com for more information.

Share article on social media or email:

LifeLearn Animal Health Announces Free CE Course “COVID-19: What we know and don’t know with Dr. Scott Weese”


News Image

LifeLearn Animal Health, in partnership with the North American Veterinary Community (NAVC) and VetFolio, today announced the launch of the veterinary CE course COVID-19: What we know and don’t know with Dr. Scott Weese, available today and free indefinitely for VetFolio subscribers.

“When it comes to COVID-19, it’s important for practices and pet owners to get the facts,” says Dr. Mark Stephenson, LifeLearn’s Chief Veterinary Officer. “Sorting out what we know and don’t know with infectious disease expert Dr. Scott Weese can help practices focus on delivering the best medicine to patients while keeping clients and team members healthy and safe.”

Offering veterinarians, veterinary technicians and anyone working in the animal health profession insights and clarification on COVID-19 as it affects animals, the course includes expert recommendations on COVID-19 risks to a clinic, pet quarantine information, social distancing practices applied in a clinic setting and more.

COVID-19: What we know and don’t know with Dr. Scott Weese has been submitted to AAVSB and is awaiting RACE approval.

“Resources and information are vital right now for all practices to safely and effectively manage their way through the COVID-19 crisis,” says Dr. Stephenson. “Free accessibility means this important course is available to all practice team members. And online veterinary courses give veterinary professionals and students the flexibility and accessibility to learn and grow how they want, when they want, while practicing safe physical distancing.”

LifeLearn’s production of the free VetFolio CE course by Dr. Weese is the company’s latest response to COVID-19 and serving the needs of practices.

“From the start of the outbreak,” says Dr. Stephenson, “LifeLearn understood that with so much information and misinformation available, it was crucial to focus on what disease experts knew and stick to the facts. LifeLearn also appreciated how time was valuable in practices and how answering questions about COVID-19 may be overwhelming for teams as they took care of day-to-day business. To help, we launched a dedicated COVID-19 Practice Resources page on the LifeLearn website to provide practices with a complete range of free tools, resources and information.”

LifeLearn’s COVID-19 Practice Resources page includes two free resources provided by Dr. Scott Weese:


  • Coronavirus Disease 2019 (COVID-19) Owner Contact Guidelines for Veterinarians, a flowchart for managing contacts and case admissions to clinics.
  • COVID-19 in Animals: The Facts from an Infectious Disease Expert (Podcast): In cooperation with LifeLearn, VetFolio’s Dr. Cassi interviews veterinary infectious disease expert Dr. Scott Weese about COVID-19 in animals. (To receive CE credit for the podcast, access the quiz from the link provided on the VetFolio podcast page.)

“Staying connected and sharing resources is how we get through crises,” adds Dr. Stephenson, “and we encourage practices everywhere to download, use and share our resources to help them get through these challenging times.”

LifeLearn also assures its customers that, while some industries have been affected by COVID-19, LifeLearn’s products, services, support, operations and resources are not affected by the outbreak. Their products and services will continue to operate reliably, with little likelihood of significant impact, and LifeLearn is focused on being available to all customers.

About Dr. Scott Weese

Dr. J. Scott Weese (DVM, DVSc, DipACVIM) is a veterinary internist and microbiologist, and Diplomate of the American College of Veterinary Internal Medicine. He is a Professor at the Ontario Veterinary College, University of Guelph, and a Zoonotic Disease/Public Health Microbiologist at the University of Guelph’s Centre for Public Health and Zoonoses. He is also Chief of Infection Control at the Ontario Veterinary College Teaching Hospital and holds a Canada Research Chair in zoonotic diseases. Dr. Weese has authored or co-authored over 200 papers in peer-reviewed journals, edited two books, and speaks extensively on infectious disease topics.

About VetFolio

Founded in 2014, VetFolio offers world-class education and resources for the entire veterinary community and provides a one-stop continuing education resource for professional and personal advancement. VetFolio’s mission is to elevate the quality of animal medical care throughout the world by providing online CE and resources for the entire veterinary community, any time, anywhere. VetFolio is a joint venture partnership between LifeLearn and NAVC.

http://www.vetfolio.com | Facebook | Twitter

About NAVC

Founded in 1982 and headquartered in Gainesville, Florida, with offices in Orlando, Florida, the North American Veterinary Community (NAVC) is a non-profit organization providing world-class professional development to the global veterinary healthcare community. Its largest initiative, VMX, formerly known as the NAVC Conference, hosts thousands of veterinary professionals each year. Other offerings include VetFolio, an online CE platform; the NAVC Institute; the Veterinary Innovation Council; an Industry Services Division, and its Media division, consisting of: Today’s Veterinary Business, Today’s Veterinary Nurse, Today’s Veterinary Practice, Veterinary Advantage and an online news and lifestyle channel, Spark!

In 2018, the NAVC launched its Certifications division including the Human-Animal Bond Certification and added the Veterinary Business Leader Certification and the Pet Nutrition Certification in 2019.

http://www.navc.com | Facebook | Instagram| Twitter

About LifeLearn Animal Health

LifeLearn empowers veterinary practices to optimize the way they do business, attract more clients, and improve profitability with a suite of customizable online solutions, including: WebDVM—custom veterinary websites; ClientEd—client education resource; Sofie—virtual DVM assistant; PetNurse—after-hours telehealth triage service; ALLYDVM—client communication + retention software.

Animal health corporations rely on LifeLearn to provide custom digital education, marketing, and communications products and services to help them market to their valued veterinary and pet-owner customers.

LifeLearn’s award-winning competencies in digital media, combined with longstanding veterinary content expertise, are just part of why LifeLearn has been named one of Canada’s Fastest-Growing Companies from 2015 to 2019.

http://www.lifelearn.com | Facebook | Twitter | LinkedIn | Instagram

For more information, contact:

NAVC

Robin Pence, Senior Director of Communication

DMiller@NAVC.com

+1 (352) 244-3719

LifeLearn

Ed Casagrande, Vice President of Marketing

(800) 375-7994, ext. 244